Evidence map›Paper›PMID 39312574›Full record

ArticlePLoS genetics2024

NEMF mutations in mice illustrate how Importin-β specific nuclear transport defects recapitulate neurodegenerative disease hallmarks.

Jonathan Plessis-Belair, Kathryn Ravano, Ellen Han, Aubrey Janniello, Catalina Molina, Roger B Sher

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan Plessis-BelairDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.ORCID https://orcid.org/0000-0002-3997-0421
Kathryn RavanoDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.ORCID https://orcid.org/0009-0006-5471-8458
Ellen HanDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.
Aubrey JannielloDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.
Catalina MolinaDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.ORCID https://orcid.org/0009-0009-9233-4035
Roger B SherDepartment of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York, United States of America.ORCID https://orcid.org/0000-0003-3327-537X

Funding

Effects of TDP-43 Proteinopathy on Retrotransposon Activation and Cell-Type Specific Vulnerability in a Mammalian Model of Alzheimer's and Related DementiasR01AG079898 · NIA · STATE UNIVERSITY NEW YORK STONY BROOK · PI ROGER B SHER · 2023 to 2026
$2.3M
NIA NIH HHS R01 AG079898
6 · The paper itself

Abstract

Pathological disruption of Nucleocytoplasmic Transport (NCT), such as the mis-localization of nuclear pore complex proteins (Nups), nuclear transport receptors, Ran-GTPase, and RanGAP1, are seen in both animal models and in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), frontal temporal dementia and frontal temporal lobar degeneration (FTD\FTLD), and Alzheimer's and Alzheimer's Related Dementias (AD/ADRD). However, the question of whether these alterations represent a primary cause, or a downstream consequence of disease is unclear, and what upstream factors may account for these defects are unknown. Here, we report four key findings that shed light on the upstream causal role of Importin-β-specific nuclear transport defects in disease onset. First, taking advantage of two novel mouse models of NEMF neurodegeneration (NemfR86S and NemfR487G) that recapitulate many cellular and biochemical aspects of neurodegenerative diseases, we find an Importin-β-specific nuclear import block. Second, we observe cytoplasmic mis-localization and aggregation of multiple proteins implicated in the pathogenesis of ALS/FTD and AD/ADRD, including TDP43, Importin-β, RanGap1, and Ran. These findings are further supported by a pathological interaction between Importin-β and the mutant NEMFR86S protein in cytoplasmic accumulations. Third, we identify similar transcriptional dysregulation in key genes associated with neurodegenerative disease. Lastly, we show that even transient pharmaceutical inhibition of Importin-β in both mouse and human neuronal and non-neuronal cells induces key proteinopathies and transcriptional alterations seen in our mouse models and in neurodegeneration. Our convergent results between mouse and human neuronal and non-neuronal cellular biology provide mechanistic evidence that many of the mis-localized proteins and dysregulated transcriptional events seen in multiple neurodegenerative diseases may in fact arise primarily from a primary upstream defect in Importin- β nuclear import. These findings have critical implications for investigating how sporadic forms of neurodegeneration may arise from presently unidentified genetic and environmental perturbations in Importin-β function.

Indexed as

Active Transport, Cell Nucleusbeta KaryopherinsDisease Models, AnimalNeurodegenerative DiseasesAlzheimer DiseaseAmyotrophic Lateral SclerosisAnimalsCell NucleusFrontotemporal DementiaFrontotemporal Lobar DegenerationHumansMiceMutationran GTP-Binding Proteinbeta Karyopherinsran GTP-Binding Protein

Identifiers

PMID39312574
PMCPMC11449308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.